title: Has IMPROVE-IT improved cardiovascular outcome?
authors.affiliation: LD Ferguson, Chemical Pathology & Metabolic Medicine, Department of Clinical Biochemistry, MacEwen Building, Glasgow Royal Infirmary, Glasgow, UK. Email lyn.ferguson@glasgow.ac.uk.
authors.forename: L D
authors.initials: LD
authors.lastname: Ferguson
authors.forename: J
authors.initials: J
authors.lastname: Logue
mesh_terms: D054058:Acute Coronary Syndrome / Q000150:complications / Q000188:drug therapy; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D000069438:Ezetimibe / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D000069438:Ezetimibe